Not to be conspiratorial, but I'm reminded of when recommended cholesterol levels were reduced significantly, right around the time statins became widely available. Are we now seeing something similar with the availability of GLP-1 drugs? I wouldn't be surprised if the pharmaceutical industry, which stands to sell more drugs as a result of this change, is using its influence here. But I also recognize that the changes might be entirely beneficial. Are there studies that compare (1) outcomes that result from weight loss with the new drugs with (2) outcomes of weight loss without the drugs, and also with (3) outcomes without weight loss? I can imagine that outcomes for (2) could be superior if they're the result of better nutrition and more exercise.